nafazatrom has been researched along with Blood Clot in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herrmann, KS; Voigt, WH | 1 |
| Breddin, HK; Pauliks, V; Weichert, W | 1 |
| Elder, MG; Myatt, L | 1 |
| Blajchman, M; Buchanan, MR; Hirsh, J | 1 |
| Cannizzaro, S; Davì, G; Giubilato, A; Strano, A | 1 |
| Boulu, RG; Massad, L; Plotkine, M | 1 |
1 review(s) available for nafazatrom and Blood Clot
| Article | Year |
|---|---|
[Platelet function inhibitors in peripheral arteriopathies].
Topics: Adrenal Cortex Hormones; Adrenergic alpha-Antagonists; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Arteriosclerosis Obliterans; Aspirin; Blood Platelets; Calcium Channel Blockers; Clinical Trials as Topic; Cyclic AMP; Dipyridamole; Extremities; Heparin; Humans; Imidazoles; Prostaglandins; Prostanoic Acids; Pyrazoles; Pyrazolones; Quinacrine; Thiophenes; Thromboembolism; Thrombosis; Ticlopidine; Vascular Diseases | 1986 |
1 trial(s) available for nafazatrom and Blood Clot
| Article | Year |
|---|---|
[Platelet function inhibitors in peripheral arteriopathies].
Topics: Adrenal Cortex Hormones; Adrenergic alpha-Antagonists; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Arteriosclerosis Obliterans; Aspirin; Blood Platelets; Calcium Channel Blockers; Clinical Trials as Topic; Cyclic AMP; Dipyridamole; Extremities; Heparin; Humans; Imidazoles; Prostaglandins; Prostanoic Acids; Pyrazoles; Pyrazolones; Quinacrine; Thiophenes; Thromboembolism; Thrombosis; Ticlopidine; Vascular Diseases | 1986 |
5 other study(ies) available for nafazatrom and Blood Clot
| Article | Year |
|---|---|
Ultrastructural observations of an electron dense amorphous layer on selectively damaged endothelial cells, a possible trigger of thrombogenesis in vivo, and its inhibition by nafazatrom.
Topics: Animals; Cheek; Cricetinae; Dextrans; Endothelium; Fluorescein-5-isothiocyanate; Fluoresceins; Mesocricetus; Microscopy, Electron; Platelet Aggregation; Pyrazoles; Pyrazolones; Thrombosis | 1984 |
Laser-induced thrombi in rat mesenteric vessels and antithrombotic drugs.
Topics: Animals; Aspirin; Blood Platelets; Dipyridamole; Disease Models, Animal; Fibrinolytic Agents; Heparin; Lasers; Male; Mesenteric Arteries; Mesenteric Vascular Occlusion; Molsidomine; Oxazoles; Platelet Aggregation; Propionates; Pyrazoles; Pyrazolones; Rats; Rats, Inbred Strains; Sydnones; Thiophenes; Thrombosis; Ticlopidine | 1983 |
First use of nafazatrom, a new antithrombotic drug, in pregnancy.
Topics: Adult; Female; Fibrinolytic Agents; Humans; Infant, Newborn; Infarction; Placenta; Pregnancy; Pregnancy Complications, Cardiovascular; Pyrazoles; Pyrazolones; Thrombosis | 1984 |
Inhibition of arterial thrombosis and platelet function by nafazatrom.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Epoprostenol; Fibrinolytic Agents; In Vitro Techniques; Platelet Aggregation; Platelet Count; Prostaglandins F; Pyrazoles; Pyrazolones; Rabbits; Thrombosis | 1982 |
Investigations on the role of arachidonic acid metabolism pathways in the antithrombotic activity of nafazatrom and molsidomine.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Epoprostenol; Fibrinolytic Agents; Male; Molsidomine; Pyrazoles; Pyrazolones; Rats; Rats, Inbred Strains; Thrombosis | 1988 |